Legal Representation
Attorney
Edward D. Lanquist, Jr.
USPTO Deadlines
Next Deadline
33 days remaining
NOA E-Mailed - SOU Required
Due Date
August 11, 2025
Extension Available
Until February 11, 2026
Application History
50 events| Date | Code | Type | Description |
|---|---|---|---|
| Apr 1, 2025 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Mar 5, 2025 | CHPB | I | POST PUBLICATION AMENDMENT - ENTERED |
| Mar 3, 2025 | APET | A | ASSIGNED TO PETITION STAFF |
| Feb 11, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Jan 27, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Jan 27, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Jan 27, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Jan 27, 2025 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Dec 17, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Dec 17, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Dec 11, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Nov 19, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Nov 19, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Nov 19, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| Nov 19, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Nov 19, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Nov 1, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Nov 1, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Nov 1, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Oct 9, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Oct 9, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Jul 11, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Jul 11, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Jul 11, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Jun 24, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Jun 24, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jun 24, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Mar 25, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Mar 25, 2024 | GNRT | O | NON-FINAL ACTION E-MAILED |
| Mar 25, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Feb 28, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Feb 28, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Feb 28, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Feb 28, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Feb 28, 2024 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Feb 28, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Feb 28, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Feb 22, 2024 | GAUN | O | NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED |
| Feb 22, 2024 | GAUD | O | NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED |
| Feb 22, 2024 | NAUD | R | REPORT UNRESPONSIVE AMENDMENT - COMPLETED |
| Feb 22, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Feb 22, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Feb 22, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Feb 22, 2024 | ALIE | A | ASSIGNED TO LIE |
| Oct 2, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Aug 16, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Aug 16, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Aug 16, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Aug 16, 2023 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Jul 6, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
Detailed Classifications
Class 044
Consultation services in the fields of healthcare concerning hospitalization and readmission risk; Consulting services relating to medical, pharmaceutical, and health data analysis for treatment and diagnostic purposes to assist healthcare providers to determine patients' hospitalization and readmission risk; Providing healthcare information concerning patients' hospitalization and readmission risk; Providing medical analysis services for treatment and diagnostic purposes to determine patients' hospitalization and readmission risk; Providing online information in the field of medical analysis services for treatment and diagnostic purposes to determine patients' hospitalization and readmission risk; Analysis of health care, medical, pharmaceutical, and population health data to assist healthcare providers for treatment and diagnostic purposes
Classification
International Classes
044